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TMEM218 dysfunction causes ciliopathies,
including Joubert and Meckel syndromes
Julie C. Van De Weghe,1 Jessica L. Giordano,2 Inge B. Mathijssen,3 Majid Mojarrad,4,5,6
Dorien Lugtenberg,7 Caitlin V. Miller,1 Jennifer C. Dempsey,1 Mahsa Sadat Asl Mohajeri,4
Elizabeth van Leeuwen,8 Eva Pajkrt,8 Caroline C.W. Klaver,9 Henry Houlden,10 Atieh Eslahi,4,11
Aoife M. Waters,12 University of Washington Center for Mendelian Genomics,13
Michael J. Bamshad,1,13,14 Deborah A. Nickerson,13,14 Vimla S. Aggarwal,15 Bert B.A. de Vries,7
Reza Maroofian,10 and Dan Doherty1,16,17,*SummaryThe Joubert-Meckel syndrome spectrum is a continuum of recessive ciliopathy conditions caused by primary cilium dysfunction. The
primary cilium is a microtubule-based, antenna-like organelle that projects from the surface of most human cell types, allowing
them to respond to extracellular signals. The cilium is partitioned from the cell body by the transition zone, a known hotspot for cili-
opathy-related proteins. Despite years of Joubert syndrome (JBTS) gene discovery, the genetic cause cannot be identified in up to 30% of
individuals with JBTS, depending on the cohort, sequencing method, and criteria for pathogenic variants. Using exome and targeted
sequencing of 655 families with JBTS, we identified three individuals from two families harboring biallelic, rare, predicted-deleterious
missense TMEM218 variants. Via MatchMaker Exchange, we identified biallelic TMEM218 variants in four additional families with cili-
opathy phenotypes. Of note, four of the six families carry missense variants affecting the same highly conserved amino acid position
115. Clinical features included the molar tooth sign (N ¼ 2), occipital encephalocele (N ¼ 5, all fetuses), retinal dystrophy (N ¼ 4, all
living individuals), polycystic kidneys (N ¼ 2), and polydactyly (N ¼ 2), without liver involvement. Combined with existing functional
data linking TMEM218 to ciliary transition zone function, our human genetic data make a strong case for TMEM218 dysfunction as a
cause of ciliopathy phenotypes including JBTS with retinal dystrophy and Meckel syndrome. Identifying all genetic causes of the Jou-
bert-Meckel spectrum enables diagnostic testing, prognostic and recurrence risk counseling, and medical monitoring, as well as work to
delineate the underlying biological mechanisms and identify targets for future therapies.Introduction
Joubert syndrome (JBTS [MIM: PS213300]) is a reces-
sive, neurodevelopmental disorder defined by the
appearance of the ‘‘molar tooth sign’’ on axial MRI.
The prevalence of JBTS is estimated to be ~1/100,000
individuals.1 Since the initial description in 1969 by
Marie Joubert,2 >38 genes have been linked to JBTS.3
The pathognomonic brain imaging feature, the molar
tooth sign, consists of cerebellar vermis hypoplasia
and thick, misoriented superior cerebellar peduncles
with a deep interpeduncular fossa. People with JBTS
often have some degree of cognitive impairment, along
with ataxia, apnea/tachypnea, abnormal eye move-
ments, and hypotonia. Variable features include retinal
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PS249000), typically defined by a variable combination
of occipital encephalocele, polydactyly, polycystic kid-
neys, congenital liver fibrosis, and demise during preg-
nancy or the neonatal period. To date, approximately
one-third of JBTS-associated genes have also been
linked to Meckel syndrome. Based on the genetic and
phenotypic overlap, Joubert and Meckel syndromes
likely represent the milder and more severe ends,
respectively, of a ciliopathy spectrum.
Large cohorts of families with ciliopathies, coupled with
powerful advances in genomics and data-sharing, have facil-
itated the identification of more than 38 genes associated
with JBTS over the past decade. Despite this progress, 5%–
30% (depending on the cohort) of individuals with JBTS still
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organisms, both Vogel et al.7 and Li et al.8 predicted that
TMEM218 dysfunction could cause human ciliopathy phe-
notypes. Herein, we report discovery of biallelic pathogenic
variants in TMEM218 in 10 individuals from 6 families
affected by either Joubert or Meckel syndrome.Material and methods
Subject ascertainment and phenotypic data
All families were enrolled under approved human subjects
research protocols at the University of Washington (UW),
Columbia University Medical Center (CUMC), Radboud Univer-
sity Medical Center (RUMC), University College London (UCL),
Amsterdam University Medical Center (AUMC), and Mashhad
University of Medical Sciences, except for GM07817, which is a
fibroblast cell line from a fetus diagnosed with Meckel syndrome
of unknown genetic cause available through the Coriell cell repos-
itory. Clinical data were obtained by direct examination of partic-
ipants, review of medical records, and structured questionnaires.
Variant identification
UW samples: Individuals affected by JBTS were previously
screened using a molecular inversion probes (MIPs) targeted cap-
ture,4,9 covering AHI1 (MIM: 608894), ARL13B (MIM: 608922),
ARMC9 (MIM:617612), B9D1 (MIM: 614144), B9D2 (MIM:
611951), C2CD3 (MIM: 615944), CPLANE1 (MIM: 614571),
CC2D2A (MIM: 612013), CEP290 (MIM: 61042), CEP41 (MIM:
610523), CSPP1 (MIM: 611654), IFT172 (MIM: 607386), INPP5E
(MIM: 613037), KIF7 (MIM: 611254), MKS1 (MIM: 609883),
NPHP1 (MIM: 607100), OFD1 (MIM: 300170), RPGRIP1L (MIM:
610937), TCTN1 (MIM: 609863), TCTN2 (MIM: 613846), TCTN3
(MIM: 613847), TMEM138 (MIM: 614459), TMEM216 (MIM:
613277), TMEM231 (MIM: 614949), TMEM237 (MIM: 614423),
TMEM67 (MIM: 609884), TOGARAM1 (MIM: 617618), TTC21B
(MIM: 612014), and ZNF423 (MIM: 604557).
In samples without biallelic rare, predicted-deleterious variants
(RDVs), exome sequencing was performed as previously
described10 using Roche Nimblegen SeqCap EZ Human Exome
Library v2.0 capture probes (36.5 Mb of coding exons) and
paired-end 50 bp reads on an Illumina HiSeq sequencer. In accor-
dance with the Genome Analysis ToolKit’s (GATK) best practices,
we mapped sequence reads to the human reference genome
(hg19) using the Burrows-Wheeler Aligner (BWA, v.0.7.8),
removed duplicate reads (PicardMarkDuplicates v.1.113), and
performed indel realignment (GATK IndelRealigner v.3.1) and
base-quality recalibration (GATK TableRecalibration v.3.1). We
called variants using the GATK UnifiedGenotyper and flagged
with VariantFiltration to mark potential false positives that did
not pass the following filters: Heterozygous Allele Balance
(ABHet) > 0.75, Quality by Depth > 5.0, Quality (QUAL) > 50.0,
Homopolymer Run (Hrun) < 4.0, and low depth (< 83). We
used SeattleSeq for variant annotation and the Combined Annota-
tion Dependent Depletion (CADD) score to determine deleterious-
ness of identified missense variants.11 Based on CADD score data
for causal variants in other JBTS-associated genes, we used a
CADD score cutoff of 15 to define deleterious variants.4
CUMC family: Research trio analysis was performed as previ-
ously described.12 In brief, DNA samples were exome sequenced
by the Institute for GenomicMedicine, Columbia University Med-
ical Center. Whole exome sequencing (WES) was performed with
the KAPA Biosystem’s library preparation kit on the Illumina Hi-2 Human Genetics and Genomics Advances 2, 100016, January 14, 2Seq 2500 platform. Nimblegen SeqCap EZ version 3.0 rapid or
Nimblegen SeqCap EZ version 4 was used for capture. Bio-
informatic processing was performed by the Institute for Genomic
Medicine’s bioinformatic and trio analysis platforms using BWA
andGATK, which identified qualifying genotypes after accounting
for the parental genotypes and genotypes present in in-house and
external control reference samples. Variants with a minor allele
frequency (MAF)> 0.01 were excluded, and variants that were pre-
dicted pathogenic by American College of Medical Genetics
(ACMG) guidelines were prioritized.13 The TMEM218 variants
were validated by Sanger sequencing.
RUMC family: After a gene panel analysis for vision disorders
failed to identify biallelic RDVs, clinical exome sequencing re-
vealed the TMEM218 variants reported in this work. In brief,
exome sequencing was performed using an Illumina HiSeq system
and Agilent SureSelectXT Human All exome 50 Mb kit. Following
read alignment (BWA) and variant calling via GATK (single nucle-
otide variant, SNV) and CoNIFER (copy number variant, CNV),
variants were annotated using an in-house developed pipeline.
Variants with aMAF above 5% in Single Nucleotide Polymorphism
Database (dbSNP) and above 1% in an in-house database were
excluded. ACMG 2015 guidelines were used as criteria for variant
pathogenicity.13
UCL family: Exome sequencing was performed on DNA as pre-
viously described.14 Based on the presence of consanguinity and
a ciliopathy-related phenotype, we prioritized recessive homozy-
gous coding variants within runs of homozygosity. We excluded
synonymous variants, intronic variants (>5 bp from exon bound-
aries) and common variants (MAF, >0.001% via population
databases). Variants that were predicted pathogenic by Sorting
Intolerant From Tolerant (SIFT),15 Polymorphism Phenotyping
v2 (PolyPhen2),16 and MutationTaster17 were prioritized. The
TMEM218 variants were validated by Sanger sequencing.
AUMC family: After clinical exome sequencing with a ciliopathy
panel of 142 genes failed to identify biallelic RDVs, clinical exome
sequencing identified the pathogenic TMEM218 variants reported
here. In brief, DNA was extracted from peripheral blood samples
and enriched with the Agilent SureSelectXT Human All Exon
50 Mb Kit (Santa Clara, CA, USA). Exome sequencing was per-
formed using an Illumina NextSeq500 (San Diego, CA, USA).
Following read alignment with BWA and variant calling with
GATK, variants were annotated using an in-house developed pro-
gram at the department of Genetics of the Radboud University
Medical Center. ACMG 2015 guidelines were used as criteria for
variant pathogenicity.13 In brief, data on frequency of variants in
control populations (<5% in dbSNP and <1% in an in-house data-
base), nucleotide and amino acid conservation, inheritance pattern,
and the phenotype associated with the genes were combined to pri-
oritize variants. All reported variants that did notmeet our validated
quality standard were confirmed using Sanger sequencing.Results
TMEM218 variants cause JBTS
To identify novel genes associated with JBTS, we performed
exome sequencing on 53 individuals from a cohort of 655
families affected by JBTS, in whom we did not identify
pathogenic variants in candidate or known genes associ-
ated with the disorder.4 We identified a single individual
(UW362-4) with biallelic RDVs, affecting the same021
amino acid residue (g.124967611C>T [NC_000011.9]
[c.344G>A (GenBank: Se_001258243.1); p.Arg115His
(NP_001245172.1)] maternal and g.124967612G>A [Gen-
Bank: NC_000011.9] [c.343C>T (NM_001258243.1);
p.Arg115Cys (GenBank: NP_001245172.1)] paternal),
which are rare in gnomAD v2.118,19 and predicted to be
deleterious by the CADD algorithm (Figure 1; Table 1).11
The affected fetal sibling (UW362-3) also carried these var-
iants. We did not identify biallelic RDVs in other genes
associated with the primary cilium. We then screened
our cohort (i.e., 62 individuals with JBTS who had not
been sequenced and 229 individuals with JBTS who had
been previously sequenced but whose genetic etiology
was unknown) using small molecule molecular inversion
probes capture4,9,20 and identifiedg.124967612G>A
(GenBank: NC_000011.9) (c.343C>T [GenBank: NM_
001258243.1];p.Arg115Cys [GenBank: NP_001245172.1])
homozygous in a fetus diagnosed with Meckel syndrome
(UW363-3) (Figure 1; Table 1). Using the MyGene2 and
GeneMatcher21 nodes of MatchMaker Exchange,22 we
identified four additional families with TMEM218 variants,
all detected by exome sequencing: (1) CUMC family:
homozygousc.343C>T (GenBank: NM_001258243.1)
(p.Arg115Cys [GenBank: NP_001245172.1]) variant in
three fetuses with occipital encephaloceles from Irish par-
ents without known consanguinity (Figure 1; Table 1).
This couple also had a previous pregnancy with ultrasound
findings suspicious for lower urinary tract obstruction
at 12 weeks gestation, followed by miscarriage at
14 weeks. (2) RUMC family: homozygous g.124967611C>T
(GenBank: NC_000011.9) (c.344G>A [GenBank: NM_
001258243.1];p.Arg115His [GenBank: NP_001245172.1])
variant in two adult siblings with developmental disability
and retinal dystrophy from consanguineous Iraqi parents
(Figure 1; Table 1). (3) UCL family homozygousg.
124972112C>A (GenBank: NC_000011.9) (c.131G>T
[GenBank: NM_001258243.1];p.Gly44Val [GenBank:
NP_001245172.1]) variant in a female child with the
molar tooth sign on brain MRI from consanguineous
Irani parents (Figure 1; Table 1). (4) AUMC family:
homozygousg.124971135G>A (GenBank: NC_000011.
9) (c.280C>T [GenBank: NM_001258243.1];p.Arg94*
[GenBank: NP_001245172.1]) variant in a fetus with
encephalocele, polycystic kidneys, polydactyly, and
hypoplastic left heart syndrome from consanguineous
Pakistani parents (Figure 1; Table 1). Biallelic RDVs
were not found in other compelling candidate genes
in these families. Our best estimate is that TMEM218
dysfunction accounts for 0.16% of JS, based on
identifying biallelic TMEM218 variants in 1 out of
625 families in our cohort (105 directly sequenced and
420 with other well-established causes).
Bioinformatic tools, suchas theHOPE(Have [y]ourProtein
Explained) resource,23 predict that the missense variants re-
ported in this work disrupt protein function. Both residues
at position 44 and 115 are in conserved positions in or adja-
cent to transmembrane alpha helices, but not at predictedHumanphosphosites.24 Using Aminode, we found that resides 44
and 115 are in highly conserved and evolutionarily con-
strained regions (ECRs) across orthologs (Figure 1A).25 Ami-
node identifies sites within proteins under evolutionary
constraint. Local minima in the relative substitution score
define these evolutionarily constrained regions, which indi-
cate protein segments that are less tolerant to substitutions
and enriched for pathogenic variants.Phenotypic features associated with TMEM218
dysfunction
The classic molar tooth sign was demonstrated in the two
individuals (UW362-4 and UCL-1) for whom postnatal
brain imaging was available (Figures 2A and 2D). Vermis
hypoplasia, a likely molar tooth sign, and brainstem
dysplasia were demonstrated by fetal MRI in UW362-3
(Figures 2G–2I). Occipital encephalocele was identified
by prenatal ultrasound in five fetuses from three families
(Figures 2J and 2K). No other brain malformations were
demonstrated.
The four living individuals (UW362-4, RUMC-1, RUMC-
2, and UCL-1) have a range of developmental disability,
from full dependence for all activities of daily living
(ADLs) and non-verbal communication in UCL-1, to
requiring some support for most ADLs and single words
in UW362-4, to near independence for ADLs and simple
sentence verbal communication in the RUMC siblings.
All four individuals also have retinal dystrophy (from Leber
congenital amaurosis to early-onset rod-cone retinal dys-
trophy), but no known kidney or liver involvement (Table
1). Two fetuses (UW363-3 and AUMC-1) had polydactyly
and polycystic kidneys in addition to occipital encephalo-
cele, warranting a Meckel syndrome diagnosis (Table 1).
AUMC-1 also had hypoplastic left heart syndrome, charac-
terized by absent mitral valve, small left ventricle, large
ventriculoseptal defect, cardiomegaly, and mild pericardial
effusion. (Figures 2N and 2O; Table 1). Additional features
may have been missed in the fetuses due to early gesta-
tional age (11–12 weeks) at imaging and/or lack of autopsy.Discussion
Here we present evidence for TMEM218 dysfunction
causing ciliopathies along the Joubert-Meckel syndrome
spectrum. We identified biallelic RDVs in ten individuals
from six families. The four living affected individuals
(UW362-4, RUMC-1, RUMC-2, and UCL-1) have develop-
mental disability with retinal dystrophy, likely represent-
ing the milder end of the Joubert-Meckel spectrum. The
fetal sibling of UW362-4 (UW362-3) did not display any
additional features at time of demise. The three fetal sib-
lings (CUMC-1, CUMC-2, and CUMC-3) likely represent
the severe end of JBTS, as they had occipital encephalo-
celes identified very early in gestation. The two other fe-
tuses (UW363-3 and AUMC-1) had features consistent




































































































































UW362-3: UW362-4: UW362-1: CUMC-1: CUMC-3:
RUMC-1: RUMC-2: UCL-1: AUMC-1:
CUMC-2:
Figure 1. TMEM218 variants cause ciliopathy phenotypes
(A) The TMEM218 gene encodes a protein with three transmembrane helices. Individual variants are indicated by red arrows. The two
highly conserved missense variants are in the most evolutionarily constrained regions that are intolerant to substitutions.
(B) Pedigrees are consistent with recessive inheritance. The affected individual and fetuses are indicated with filled black shapes.
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Table 1. Clinical features associated with biallelic, pathogenic TMEM218 variants


































0.00004986 35 Irish M 12 weeks N/A OE N/A N/A N/A pregnancy
terminated
CUMC-2 F 11 weeks N/A OE N/A N/A N/A pregnancy
terminated




0.00001596 27.9 Iraqi F 25 years Y N/A Y N N overweight, 5th
finger
camptodactyly
















Abbreviations: AF, allele frequency in gnomAD18,19; CADD, Combined Annotation Dependent Depletion v1.3 score11; F, female; hmz, homozygous; LCA, Leber
congenital amaurosis; M, male; mat, maternal; MTS, molar tooth sign; N, no; N/A, not available; OE, occipital encephalocele; pat, paternal; PD, polydactyly; unk,
unknown; VH, cerebellar vermis hypoplasia; Y, yes. GenBank: NM_001258243.1.
aRod-cone dystrophy, onset < 1 year.
bPolycystic kidneys by ultrasound.polydactyly, and polycystic kidneys. Remarkably, four of
these families share the p.Arg115Cys variant. Given their
ethnic backgrounds and the presence of p.Arg115Cys in
Northwestern European (12/50,514), Other non-Finnish
European (1/32,924), and South Asian (1/30,158) individ-
uals in gnomAD,19 we cannot conclusively determine
whether p.Arg115Cys represents a founder variant or re-
sults from a mutational hotspot.
Predicted variant severity may correlate with phenotypic
severity. The homozygous nonsense variant p.Arg94* in
AUMC-1 is predicted to be the most deleterious to protein
function and is associated with the most severe phenotype
with encephalocele, polydactyly, cystic kidneys, and
hypoplastic left heart. This early stop codon is likely to
result in nonsense-mediated decay. The missense variantHumanp.Arg115Cys may be more disruptive to protein function
than the other missense variants, since all fetuses with
this homozygous variant had encephaloceles detected
early in gestation. Variants p.Arg115His and p.Gly44Val
may be less disruptive, since individuals with these vari-
ants are capable of living into adulthood. Indeed, the
CADD algorithm also ranks the variants accordingly:
p.Arg94*(40) > p.Arg115Cys(35) > p.Arg115His(27.9) >
p.Gly44Val(26.9). Additional individuals and/or func-
tional work would be needed to test this allelic series
more thoroughly.
So far, all living individuals with pathogenic TMEM218
variants have developed retinal dystrophy, and half of
the affected fetuses had cystic kidney disease. This may
indicate a higher risk for these features than individualsGenetics and Genomics Advances 2, 100016, January 14, 2021 5
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Figure 2. Imaging features associated with TMEM218-related Joubert and Meckel syndromes
(A–F) Post-natal brain MRI showing classic molar tooth sign (A and D), superior cerebellar dysplasia (B and E), and elevated roof of the
fourth ventricle (C and F) in UW362-4 (A–C) and UCL-1 (D–F).
(G–I) Fetal MRI showing likely molar tooth sign (G), cerebellar vermis hypoplasia (H), and elevated roof of the fourth ventricle (I) in
UW362-3.
(J and K) Prenatal ultrasound showing occipital encephalocele in CUMC-1 at 12 weeks gestation and AUMC-1 at 14 weeks gestation
(arrows).
(L and M) Prenatal ultrasound showing large, cystic kidneys (brackets) and post-axial hand polydactyly (numbers) in AUMC-1
at 14 weeks gestation.
(N and O) Fetal echocardiogram showing diastolic filling of the left ventricle only from the right ventricle via a ventriculoseptal defect
(red in N) and systolic filling of the great vessels predominantly from the right ventricle (blue in O) tracks in AUMC-1 at 18 weeks
gestation.with other causes of JBTS, so they should be monitored
closely with baseline kidney ultrasound, serial laboratory
testing (creatinine and/or cystatin C, and hemoglobin),
and serial ophthalmology evaluations, ideally with optical
coherence tomography.3 Liver involvement was not re-
ported, so we recommend standard monitoring for portal
hypertension (due to liver fibrosis) by serum platelet levels
and ultrasound measurement of spleen size every 1–2
years. The presence of hypoplastic left heart syndrome in
one fetus may indicate an increased risk for congenital
heart defects, which should prompt a low threshold for
echocardiogram, particularly if adequate cardiac views
were not obtained by prenatal ultrasound. Heart defects
are rare in JBTS4,26 and inconsistently documented in
Meckel syndrome,27 but cilia have been widely implicated
in congenital heart disease.28 Additionally, the identifica-
tion of a molecular genetic diagnosis allows families accu-
rate reproductive genetic counseling with options, such as
in vitro fertilization with preimplantation genetic diag-
nosis, use of a gamete donor, prenatal diagnosis via chori-
onic villus sampling or amniocentesis, and/or expectant
management.6 Human Genetics and Genomics Advances 2, 100016, January 14, 2The primary cilium is a singular organelle that senses a
wide range of chemical, light, and mechanical cues. It is
found on nearly every type of human cell, offering some
insight to the pleiotropic manifestations of ciliopathies.
The basal body (BB), a modified centriole, docks at the api-
cal plasma membrane and is the template for the ciliary
core structure, the microtubule-based axoneme. As the
doublet microtubules project upward for several microns,
the transition zone (TZ) forms at the BB-axoneme interface
and tethers the distal BB to the plasma membrane. Here
the TZ partitions the cilium from the cytoplasm by regu-
lating ciliary protein content and serving as a bi-direc-
tional diffusion barrier. The JBTS-associated proteins
localize to multiple subregions of the cilium, but the TZ
is a hotspot for ciliopathy-related proteins, and indeed,
half of the JS-associated proteins localize to the region.
TMEM218 was recently identified as a TZ component
based on endogenous tagging experiments in C. elegans.8
Through a series of genetic interaction assays, Li et al.8
found TMEM218 interacts with other TZ components in
amodule at the TZ periphery. Recent advances in super res-
olution microscopy have revealed details of TZ021
organization. The dense TZ protein network is organized
into concentric ring structures and can be functionally
separated into modules, although we are just beginning
to appreciate the plasticity of this region.8,29–31 At the
core of the TZ, JS-associated proteins RPGRIP1L, CEP290,
and CC2D2A facilitate localization of other TZ compo-
nents. NPHP1 and NPHP4 localize more peripherally. At
the utmost periphery sits another distinct module, consist-
ing of B9D1, B9D2, and several transmembrane proteins,
including TMEM218 (also TMEM216, TMEM231,
TMEM80, TMEM17, and TMEM237).8 It is enticing to
speculate that TMEM218 could be part of the ciliary neck-
lace, a series of 3 rows of particles that encircle the cilium
near the base, first observed by freeze-etch scanning elec-
tron microscopy of cilia in the mid-20th century.32 Given
its role in ciliary biology and association with so many
ciliopathy-related proteins, Li et al.8 also predicted that
deleterious variants in this gene would cause ciliopathies.
At the time, they sequenced an Italian JS cohort of 330 in-
dividuals with JS and did not find any likely pathogenic
variants.8 This is in line with our observations that
TMEM218 variants are a rare cause of JS.
At the organismal level, Tmem218/ mice display pro-
gressive retinal degeneration and cystic kidney disease but
not a brain phenotype observable by histology.7 Subtle thin-
ning of the outer segment layer in the retina was reported as
early as 14weeks of age, progressing to apronounced stageof
degeneration of both outer nuclear layer and photoreceptor
inner andouter segments by 29weeks. The cystic lesions dis-
played tubular atrophy, disrupted tubular basement mem-
branes, and inflammatory cellular infiltrates and fibrosis of
the renal tubulointerstitium. The combination of retina
and kidney involvement led authors to postulate that
TMEM218dysfunctioncould cause Senior-Løkensyndrome,
another ciliopathy defined by these features, in humans.
Our dataprovide strong evidence that TMEM218dysfunc-
tion results in ciliopathy phenotypes along the JBTS-Meckel
spectrum.Thisfinding is supportedby functionalwork local-
izing TMEM218 to the ciliary TZ and amousemodel recapit-
ulating the retinal and kidney phenotypes. Identifying the
complete genetic and phenotypic spectrum of these ciliopa-
thies directly improves diagnostic testing, guides medical
surveillance, and allows for earlier treatment of complica-
tions. In addition, defining the molecular mechanisms un-
derlying ciliopathies will serve as the basis for developing
precision treatments in the future. This potential is already
being realized with gene-specific therapies for retinal
disease.33More broadly, given the key roles for cilia in devel-
opment and mature organ function, understanding cilium
functionanddysfunction is likely tohave important impacts
on a diverse array of human conditions.Data and code availability
The UW exome data will be available through dbGaP
(dbGaP: phs000693). The clinical exomes are not publiclyHumanavailable. The variants generatedduring this study are avail-
able at ClinVar (Gene variants; ClinVar: SUB8476323).Consortia
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